Jinshi data, December 10 news, Northeast Pharmaceutical announced that the controlling shareholder of the company, Fangda Group, and the concerted action person Jiangxi Fangda Iron and Steel Group Co., Ltd. plan to increase their shareholding in the company within 6 months from the date of the announcement, with a planned increase amount of not less than 75 million yuan and not more than 150 million yuan. Fangda Iron and Steel will implement the increase plan based on a reasonable judgment of the company's stock price, and will seize the opportunity based on the fluctuation of the company's stock price and the overall trend of the capital market. The source of the increase fund is Fangda Iron and Steel's own funds and special loans.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Northeast Pharmaceutical: Fangda Steel plans to increase its shareholding by 75 million yuan to 150 million yuan
Jinshi data, December 10 news, Northeast Pharmaceutical announced that the controlling shareholder of the company, Fangda Group, and the concerted action person Jiangxi Fangda Iron and Steel Group Co., Ltd. plan to increase their shareholding in the company within 6 months from the date of the announcement, with a planned increase amount of not less than 75 million yuan and not more than 150 million yuan. Fangda Iron and Steel will implement the increase plan based on a reasonable judgment of the company's stock price, and will seize the opportunity based on the fluctuation of the company's stock price and the overall trend of the capital market. The source of the increase fund is Fangda Iron and Steel's own funds and special loans.